Gosset Cardiac myocyte Overview
Cardiac myocytes (cardiomyocytes) are the contractile muscle cells of the heart myocardium, responsible for the coordinated contractions that pump blood. They are characterized by high expression of sarcomere proteins (e.g., TTN, MYBPC3, TNNT2), advanced calcium-handling machinery, and abundant mitochondria to meet intense energy demands [1][3][5]. While current therapies for heart disease often modulate molecular targets within cardiac myocytes (such as ion channels or signaling pathways), the cardiac myocyte itself is not a singular molecular target but a cell type integral to heart function and disease pathophysiology. Dysfunction or loss of cardiac myocytes underlies many forms of heart failure and cardiomyopathy, and new therapeutic approaches (such as stem cell or exosome therapy) aim to restore or protect these cells [4][6].
Mechanism of Action
Modulation of ion channels (e.g., sodium, calcium, potassium channels); Modulation of adrenergic signaling (by beta-blockers); Inhibition of calcium influx (by calcium channel blockers); Influence on gene transcription/signaling pathways (e.g., via PKC, PI3K/Akt)
Biological Functions
Disease Associations
Safety Considerations
- Off-target toxicity (e.g., drug-induced arrhythmias)
- Cardiotoxicity from chemotherapy drugs (e.g., doxorubicin)
- Difficulty in regenerating damaged cardiac myocytes (limited native proliferation)
Interacting Drugs
Associated Biomarkers
| Biomarker |
|---|
| Cardiac troponins (I, T) |
| Brain natriuretic peptide (BNP, NT-proBNP) |
| Myosin light chain 2 (MYL2) |